1. AB0363 Coadministration of asp015k, a novel janus kinase inhibitor, with methotrexate demonstrates tolerability and lack of pharmacokinetic interactions in patients with rheumatoid arthritis. (23rd January 2014) Authors: Zhu, T.; Oda, K.; Valluri, U.; Moore, B.; Cao, Y.; Chindalore, V.; Akinlade, B. Journal: Annals of the rheumatic diseases Issue: Volume 72:Supplement 3(2013) Page Start: A898 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. FRI0084 SAFETY, PHARMACOKINETICS, PHARMACODYNAMICS, IMMUNOGENICITY, AND PRELIMINARY EFFICACY OF ROZIBAFUSP ALFA IN SUBJECTS WITH RHEUMATOID ARTHRITIS: INTERIM ANALYSIS OF A PHASE 1B RANDOMIZED, PLACEBO-CONTROLLED, MULTIPLE ASCENDING DOSE CLINICAL TRIAL. (2nd June 2020) Authors: Abuqayyas, L.; Cheng, L.; Mitragotri, D.; Smith, S.; Teixeira Dos Santos, M.; Zhou, Y.; Chindalore, V.; Cohen, S.; Kivitz, A.; Posch, M.; Sullivan, B.; Parnes, J. Journal: Annals of the rheumatic diseases Issue: Volume 79(2020)Supplement 1 Page Start: 619 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. THU0054 NKTR-358, A NOVEL IL-2 CONJUGATE, STIMULATES HIGH LEVELS OF REGULATORY T CELLS IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS. (2nd June 2020) Authors: Siddhanti, S.; Fanton, C.; Dixit, N.; Lu, L.; Chindalore, V.; Levin, R.; Diab, I.; Furie, R.; Zalevsky, J.; Kotzin, B. Journal: Annals of the rheumatic diseases Issue: Volume 79(2020)Supplement 1 Page Start: 238 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗